Teva Moves On From Restructuring To Improving Margins

As Israeli Firm Sees Mixed Impact From COVID-19 Pandemic

Margin
Teva is keeping a close eye on its profit margins • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business